Eden Research plc (LON:EDEN – Get Free Report) was up 12.1% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.12 ($0.05) and last traded at GBX 4.03 ($0.05). Approximately 11,523,212 shares traded hands during trading, an increase of 637% from the average daily volume of 1,562,485 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Trading Up 11.9 %
The firm has a market cap of £21.49 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42. The business has a 50-day moving average of GBX 3.88 and a 200-day moving average of GBX 4.02.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Stories
- Five stocks we like better than Eden Research
- Basic Materials Stocks Investing
- Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Momentum Grows for These 3 Healthcare Stocks
- How Can Investors Benefit From After-Hours Trading
- 3 Stocks Upgraded by Bank of America – Here’s Why They’re Bullish
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
